FindTrial
Sign In

The effect of VEGF - B signaling pathway on obesity metabolic abnormalities

The effect of VEGF - B signaling pathway on obesity metabolic abnormalities

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17011188
Enrollment
Unknown
Registered
2017-04-19
Start date
2017-04-12
Completion date
Unknown
Last updated
2017-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity

Interventions

Case series:Nil

Sponsors

Department of Endocrinology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Obesity (BMI = 28kg/m2) without metabolic disorders subjects, or obese patients with metabolic disorders, Or normal body weight (18.5 kg/m2 = BMI <24 kg/m2) without metabolic disorders subjects, or normal body weight with metabolic disorders subjects.

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
plasma insulin;plasma VEGF-B;the methylation status of VEGF-B gene promoter region;VEGF-B genomic protein methylation level;—

Countries

China

Contacts

Public ContactChen Lulu

Department of Endocrinology, Union Hospital,Tongji Medical College, Huazhong University of Science and Technology

cheria_chen@126.com+86 02785726799

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026